Zobrazeno 1 - 10
of 31
pro vyhledávání: '"W S, Colucci"'
Autor:
C, Communal, W S, Colucci
Publikováno v:
Archives des maladies du coeur et des vaisseaux. 98(3)
Cardiomyocyte death resulting from apoptosis has been implicated in the evolution of heart failure. In this review, we focus on the concept that the cardiotoxicity of excessive sympathetic nervous system activity observed in heart failure is in part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a77fa43dc599f9e9f62a64faa4c705f9
https://pubmed.ncbi.nlm.nih.gov/15816327
https://pubmed.ncbi.nlm.nih.gov/15816327
Autor:
T. Pop, J. Berger, D. Abernethy, W. S. Colucci, K. Von Olshausen, Lemuel A. Moyé, J. N. Cohn, M. Packer
Publikováno v:
New England Journal of Medicine. 335:1318-1320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04e04db8628c73897baaf67fa8c0ff0d
https://doi.org/10.1056/nejm199610243351711
https://doi.org/10.1056/nejm199610243351711
Autor:
M B, Fowler, M, Vera-Llonch, G, Oster, M R, Bristow, J N, Cohn, W S, Colucci, E M, Gilbert, M A, Lukas, M J, Lacey, R, Richner, S T, Young, M, Packer
Publikováno v:
Journal of the American College of Cardiology. 37(6)
Carvedilol reduces disease progression in heart failure, but to our knowledge, its effects on hospitalizations and costs have not been evaluated.We examined the effects on hospitalization frequency and costs in the U.S. Carvedilol Heart Failure Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd14b550d1908147b3a00c9ee755806f
https://pubmed.ncbi.nlm.nih.gov/11345386
https://pubmed.ncbi.nlm.nih.gov/11345386
Autor:
M T, Slawsky, W S, Colucci, S S, Gottlieb, B H, Greenberg, E, Haeusslein, J, Hare, S, Hutchins, C V, Leier, T H, LeJemtel, E, Loh, J, Nicklas, D, Ogilby, B N, Singh, W, Smith
Publikováno v:
Circulation. 102(18)
We determined the short-term hemodynamic and clinical effects of levosimendan, a novel calcium-sensitizing agent, in patients with decompensated heart failure.One hundred forty-six patients with New York Heart Association functional class III or IV h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::771d0d56cbac09e8e4f06e40ef78d334
https://pubmed.ncbi.nlm.nih.gov/11056096
https://pubmed.ncbi.nlm.nih.gov/11056096
Publikováno v:
Journal of cardiac failure. 6(2)
Knowledge of left-sided cardiac filling pressures has an important role in the management of patients with chronic heart failure. However, the use of a pulmonary artery catheter to measure pulmonary capillary wedge pressure is generally reserved for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da48f22a3279533c9c9c561f6769e5ef
https://pubmed.ncbi.nlm.nih.gov/10908090
https://pubmed.ncbi.nlm.nih.gov/10908090
Publikováno v:
Journal of cardiac failure. 6(2 Suppl 1)
Sympathetic nervous system activity to the myocardium is increased in patients with heart failure. It is now appreciated that norepinephrine (NE), the primary sympathetic neurotransmitter, can exert direct adverse effects on cardiac myocytes and migh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00fc4395ff3da7b77fa66133527509fa
https://pubmed.ncbi.nlm.nih.gov/10908092
https://pubmed.ncbi.nlm.nih.gov/10908092
Publikováno v:
The Journal of biological chemistry. 275(25)
We have shown that stimulation of beta-adrenergic receptors (beta-AR) by norepinephrine (NE) increases apoptosis in adult rat ventricular myocytes (ARVMs) via a cAMP-dependent mechanism that is antagonized by activation of G(i) protein. The family of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e938609afa5b14a55509064927e756d
https://pubmed.ncbi.nlm.nih.gov/10770956
https://pubmed.ncbi.nlm.nih.gov/10770956
Autor:
D. B. Sawyer, W. S. Colucci
Publikováno v:
Molecular Approaches to Heart Failure Therapy ISBN: 9783642633324
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94509f98c3877d86320482380c92b5a7
https://doi.org/10.1007/978-3-642-57710-9_18
https://doi.org/10.1007/978-3-642-57710-9_18
Autor:
J N, Cohn, M B, Fowler, M R, Bristow, W S, Colucci, E M, Gilbert, V, Kinhal, S K, Krueger, T, Lejemtel, K A, Narahara, M, Packer, S T, Young, T L, Holcslaw, M A, Lukas
Publikováno v:
Journal of cardiac failure. 3(3)
Many patients remain markedly symptomatic despite optimal current therapy for heart failure. Beta-blockers have often been viewed as contraindicated in this group because of their potential adverse short-term effects on cardiac function.One hundred t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0415c5242e4d049dd0bea74b9ede3bb3
https://pubmed.ncbi.nlm.nih.gov/9330125
https://pubmed.ncbi.nlm.nih.gov/9330125
Autor:
W S, Colucci, M, Packer, M R, Bristow, E M, Gilbert, J N, Cohn, M B, Fowler, S K, Krueger, R, Hershberger, B F, Uretsky, J A, Bowers, J D, Sackner-Bernstein, S T, Young, T L, Holcslaw, M A, Lukas
Publikováno v:
Circulation. 94(11)
We tested the hypothesis that carvedilol inhibits clinical progression in patients with mildly symptomatic heart failure due to left ventricular (LV) systolic dysfunction.Patients (n = 366) who had mildly symptomatic heart failure with an LV ejection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4637a0575afe461a21b5c8d56ae2563
https://pubmed.ncbi.nlm.nih.gov/8941106
https://pubmed.ncbi.nlm.nih.gov/8941106